Construction method of circadian rhythm disorder non-alcoholic fatty liver disease mouse model

By inducing circadian rhythm disorder in mice through adjusting light patterns and a high-fat diet, a simple and universally applicable mouse model of non-alcoholic fatty liver disease with disrupted diurnal rhythms was constructed. This solved the problems of long model construction time and large heterogeneity among individuals in existing technologies, and achieved highly stable NAFLD simulation.

CN118923623APending Publication Date: 2024-11-12NINGBO MEDICAL CENT LIHUILI HOSPITACL

Patent Information

Application Number
CN202411161093.6
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-22
Publication Date
2024-11-12

AI Technical Summary

Technical Problem

Existing technologies lack simple, universal, and stable mouse models of non-alcoholic fatty liver disease (NAFLD) with circadian rhythm disorders, making it difficult to effectively simulate the effects of circadian rhythm disorders on NAFLD. Furthermore, model construction takes a long time, and there is significant heterogeneity among individuals, making it difficult to promote widespread application.

Method used

By adjusting the light patterns in mice, including a cycle of 12 hours of light followed by 3 days of 12 hours of darkness and then 4 days of 24 hours of darkness, combined with a 60% high-fat diet, the circadian rhythm disorder was induced in mice, thus establishing a mouse model of non-alcoholic fatty liver disease with circadian rhythm disorder.

Benefits of technology

The constructed model reflects the histological characteristics of NAFLD patients on a high-fat diet under circadian rhythm disruption. It has low inter-individual heterogeneity and high stability, with significant hepatic steatosis and inflammatory infiltration, and significantly elevated serum transaminases, making it suitable as a platform for drug testing and disease mechanism research.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118923623A_ABST
    Figure CN118923623A_ABST
Patent Text Reader

Abstract

The invention discloses a method for constructing a circadian rhythm disorder non-alcoholic fatty liver disease mouse model, which comprises the following steps of: 1) keeping 6-7 weeks old mice in a free eating and water feeding state by 60% high fat diet and conventional drinking water; the illumination mode of the feeding environment where the mice are located is adjusted, and the specific one-cycle environment illumination program is as follows: illumination is performed for 12 hours to 12 hours for 3 days, and then darkness is performed for 24 hours for 4 days; and after 14 cycles in the step 2), obtaining the circadian rhythm disorder non-alcoholic fatty liver disease mouse model induced by changing the illumination mode. According to the method, the biological clock disorder of the mouse is induced in a mode of adjusting the illumination mode, the intervention causes little damage to the mouse and is closer to the occurrence and development process of natural circadian rhythm disorder, and the obtained mouse model can be used for researching disease pathogenesis and evaluating treatment methods.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the technical field of disease model construction, and in particular to a method for constructing a circadian rhythm disordered non-alcoholic fatty liver disease mouse model. Background Art

[0002] Non-alcoholic fatty liver disease (NAFLD) has a continuous spectrum of diseases: from simple non-alcoholic fatty liver (NAFL) characterized by fatty degeneration of the liver with or without mild inflammation; to non-alcoholic steatohepatitis (NASH) characterized by necrotic inflammation and fibrosis progression, which can further progress to non-alcoholic fatty liver cirrhosis and liver cancer. The incidence and prevalence of NAFLD have increased year by year both globally and in China. NAFLD has now become one of the most common causes of chronic liver disease worldwide, resulting in huge medical expenses, and the global burden of NAFLD is gradually increasing. In terms of NAFLD treatment, although many research teams around the world have conducted extensive research and development on the treatment of NAFLD, the treatment methods for NAFLD are still very limited. At present, in addition to lifestyle changes, few drugs that specifically target NAFLD and improve its prognosis have been approved for medical treatment. Although the only new drug has been launched recently, it is currently expensive, difficult to popularize, and has uncertain long-term efficacy.

[0003] With the progress of research, the pathogenesis of NAFLD has evolved from the "two-hit theory" in 1998 to the "multiple-hit theory", which is a complex multi-step, multi-organ systemic metabolic disorder induced by factors such as genetics, obesity, poor diet, and circadian rhythm disorders. In recent years, the role of biological clocks in physiology and pathology has been recognized internationally. For billions of years, various organisms have evolved circadian rhythm mechanisms in order to adapt to the evolution of light and dark cycles in the most appropriate physiological state, setting an adaptive rhythm for various physiological mechanisms; with the development of modern society, humans are affected by various living habits such as sleep deprivation, shift work, and jet lag, which lead to circadian rhythm disorders in the body, causing different metabolic diseases and even cancer. Many studies have explored the role of circadian rhythm in the body's metabolism. For example, sugar metabolism, lipid metabolism, cholesterol, and bile acid metabolism are all affected by circadian rhythms and are highly dynamic. NAFLD is closely related to metabolism. Studies have found that circadian rhythm disorders can lead to the progression of NAFLD.

[0004] The disturbance of mouse circadian clock is currently mainly induced by gene modification, time-restricted diet and changes in light patterns, among which the induction method of changing light patterns is closer to the circadian rhythm disorder process caused by sleep deprivation, shift work, jet lag, etc. Although Christie S et al. and Xie X et al. have induced circadian clock disorders in rodents by changing light patterns (3 days of 12 hours of light / 12 hours of darkness + 4 days of 12 hours of darkness / 12 hours of light, a total of 8 weeks; 4 hours of light / 20 hours of darkness or 20 hours of light / 4 hours of darkness, a total of 5 weeks), and found that circadian rhythm disorders worsened their lipid metabolism, the above two studies mainly explored the relationship between circadian rhythm and metabolism, and only performed oil red staining on the liver, lacking detailed evaluation of mouse liver inflammation, ballooning degeneration, etc. At present, only Zheng R et al. have induced a circadian rhythm disordered non-alcoholic fatty liver disease model in mice by 16 weeks of jet lag (3 days of normal light, 4 days of light and darkness both advanced by 8 hours). They found that mice with abnormal jet lag and high-fat and high-sugar diet had significantly increased liver fatty degeneration and inflammatory infiltration, increased serum aspartate aminotransferase levels, and significantly increased body weight and visceral fat mass to body weight ratio compared with the normal jet lag group. However, there were no significant differences in alanine aminotransferase levels, visceral fat mass, lipid profile, and fasting blood glucose. In addition, the model takes a long time to establish, has poor universality, and is not easy to promote. Currently, there is an urgent need to establish a circadian rhythm disordered non-alcoholic fatty liver disease mouse model that is simple to establish, has good universality, is easy to promote, has low inter-individual heterogeneity, and has relatively high stability and reproducibility. Summary of the invention

[0005] The present invention aims to at least partially overcome the above-mentioned technical problems and / or other potential problems existing in the prior art: to provide a method for constructing a mouse model of non-alcoholic fatty liver disease with circadian rhythm disorder. The model constructed by this method has the advantages of simple modeling, good universality, and easy promotion. At the same time, the model constructed by the present invention can reflect the histological characteristics of patients with non-alcoholic fatty liver disease with circadian rhythm disorder and high-fat diet, and has low inter-individual heterogeneity and relatively high stability and reproducibility.

[0006] The technical solution of the present invention is as follows: A method for constructing a circadian rhythm disorder non-alcoholic fatty liver disease mouse model, comprising the following steps:

[0007] 1) 6-7 week old mice were fed a 60% high-fat diet and regular drinking water, with free access to food and water;

[0008] 2) Adjust the lighting pattern of the environment where the mice are kept. The specific lighting program for one cycle is as follows: first, 12 hours light-12 hours dark for 3 days, then 24 hours dark for 4 days;

[0009] 3) After the 14 cycles described in step 2), a mouse model of non-alcoholic fatty liver disease with circadian rhythm disorder induced by changing the light pattern is obtained.

[0010] Preferably, the mouse is an SPF male C57BL / 6J mouse.

[0011] Preferably, the high-fat diet is a high-fat diet of model D12492 produced by Research Diets, Inc., USA.

[0012] Preferably, the light intensity in step 2) is 20 lux.

[0013] The present invention also provides an application of a circadian rhythm disorder non-alcoholic fatty liver disease mouse model constructed by the construction method in studying the influence of circadian rhythm disorder on the occurrence and development of non-alcoholic fatty liver disease.

[0014] The beneficial effects of the present invention are as follows: the present application uses the method of adjusting the light pattern to induce biological clock disorders in mice. This intervention causes little damage to mice and is closer to the occurrence and development process of natural circadian rhythm disorders. The model constructed by the present invention reflects the histological characteristics of patients with circadian rhythm disorder and high-fat diet non-alcoholic fatty liver disease. Liver fatty degeneration and intralobular inflammatory infiltration are significantly aggravated, serum alanine aminotransferase and aspartate aminotransferase are significantly increased, and the model mice show changes in general living conditions and changes in liver biological clock gene expression. By adjusting the light pattern, the model of the present invention shows low inter-individual heterogeneity and relatively high stability and reproducibility. It can be used as a platform for testing therapeutic drugs and studying the pathogenesis of diseases, and has broad application prospects. BRIEF DESCRIPTION OF THE DRAWINGS

[0015] Figure 1 The following are the general living status curves of the mice in each group in the embodiment; wherein, (a) body weight curve; (b) total diet curve (per week); (c) diet curve during LD; (d) diet curve during DD; (e) total water drinking curve (per week); (f) water drinking curve during LD; (g) water drinking curve during DD; (h) 5 min activity level at rest (measured at the end of LD period).

[0016] Figure 2 The liver clock gene expression levels of mice in the HFD-CRD and HFD-LD groups in the examples, including: (a) Rev-erbα mRNA expression level; (b) Bmal1 mRNA expression level; (c) Rorα mRNA expression level; (d) Per1 mRNA expression level; (e) Per2 mRNA expression level.

[0017] Figure 3The serum liver function indexes of each group of mice in the example, including (a) serum ALT; (b) serum AST.

[0018] Figure 4 The liver tissue pathology (HE staining) of each group of mice in the example. DETAILED DESCRIPTION

[0019] The present invention is further described in detail below with specific examples, but the present invention is not limited to the following specific examples.

[0020] Example

[0021] 1. Materials and Methods

[0022] 1.1 Animals

[0023] SPF male C57BL / 6J mice, 4 weeks old, weighing approximately 12 g, were purchased from Weitong Lihua Experimental Animal Technology Co., Ltd., animal production license number SCXK (Beijing) 2019-0009. Mice were housed in an SPF environment at the Animal Experiment Center of Ningbo University (room temperature 23 ± 2 °C, humidity 50% to 60%, wind speed ≤ 0.2 m / s, ventilation 15-20 times / day, light intensity 20 lux, 12 h light / 12 h dark cycle), with free access to water and food. All procedures were performed in accordance with protocols approved by the Animal Care and Use Committee of Ningbo University.

[0024] 1.2 Adjust the lighting mode and obtain mouse tissue

[0025] The mice were randomly divided into three groups, namely, normal diet and normal circadian rhythm group (ND-LD group, n=6), high-fat diet and normal circadian rhythm group (HFD-LD group, n=17), and high-fat diet and circadian rhythm disorder group (HFD-CRD group, n=18), and were given corresponding feeds, namely ordinary feed (provided by the Animal Experiment Center of Ningbo University) and 60% high-fat feed (purchased from ResearchDiets, USA, model D12492), respectively, and the diet was adapted for 2 weeks. Afterwards, the ND-LD group and the HFD-LD group were fed with corresponding feeds and normal light mode (12 hours light / 12 hours dark), and the HFD-CRD group was fed with corresponding feeds and abnormal light mode (12 hours light / 12 hours dark, LD 3 days + 24 hours dark, DD 4 days), and the mice were fed for 14 weeks. The amount of food and water consumed, the amount of exercise in 5 minutes at rest, and the body weight of the mice were measured regularly. After 14 weeks, 6 mice in the ND-LD group, 6 mice in the HFD-LD group and 6 mice in the HFD-CRD group were randomly selected (the remaining mice were used for subsequent experiments) and fasted but not deprived of water. The mice were killed at Zeitgeber Time 0 (ZT0, 8:00 am) the next day, and the serum and liver of the mice were obtained. Except for the 1 / 2 largest liver lobe immersed in formalin, the rest of the tissues were frozen at -80℃.

[0026] 1.3 Food intake, water intake, 5-minute exercise at rest, and body weight measurement

[0027] After changing the lighting mode every week, the food intake, water intake, 5-minute activity level at rest, and body weight of all mice were measured. There were 3 mice in each cage, and cages with less than 3 mice were removed.

[0028] 1.4 Serum biochemical analysis

[0029] The serum samples were placed on ice, and the liver function injury indicators ALT and AST in mouse serum were detected by rate method or endpoint method according to the kit instructions of Ningbo Meikang Biotechnology Co., Ltd., and the data were processed and analyzed.

[0030] 1.5 Liver histopathological analysis

[0031] After fixation and embedding in paraffin, the liver tissue was cut into 5 μm sections. Subsequently, the sectioned tissue was stained with hematoxylin and eosin (H&E) and then observed under an optical microscope. The histological scoring system for nonalcoholic fatty liver disease was performed according to the NAS scoring system (NAS).

[0032] 1.6 Quantitative polymerase chain reaction

[0033] Total RNA was extracted from 20 mg of liver tissue using the TransZol Up Plus RNA Kit (Beijing Quanshijin Biotechnology Co., Ltd., China). 1000 ng of RNA was reverse transcribed using a reverse transcription kit (Beijing Quanshijin Biotechnology Co., Ltd., China). Real-time PCR was performed using SYBR Green Master Mix (Beijing Quanshijin Biotechnology Co., Ltd., China) in a fluorescent quantitative PCR instrument (ABI, USA). Primers were designed using the NCBI Primer BLAST tool. Using 18SrRNA as an internal reference, 2ΔΔCt was used to relatively quantify the transcription level of the target gene mRNA to compare the expression differences of the target gene between the groups. The primer sequences are shown in Table 1:

[0034] Table 1 Quantitative polymerase chain reaction primers

[0035] Gene Forward Primer Post Primer Rev-erbα (SEQ ID NO:1)TTTTTCGCCGGAGCATCCAA (SEQ ID NO:2)ATCTCGGCAAGCATCCGTTG Bmal1 (SEQ ID NO:3)TGACCCTCATGGAAGGTTAGAA (SEQ ID NO:4)GGACATTGCATTGCATGTTGG Per1 (SEQ ID NO:5)CTGAAGCAAGACCGGGAGAG (SEQ ID NO:6)CAGCCCCAATCCATCCAGTT Per2 (SEQ ID NO:7)GAAGCGCCTAGAATCCCTCC (SEQ ID NO:8)TTCTTGTGGATGGCGAGCAT Rorα (SEQ ID NO:9)ATGCCACCTACTCCTGTCCT (SEQ ID NO:10)GCTTCTTGGACATCCGACCA 18S rRNA (SEQ ID NO:11)ATTGGAGCTGGAATTACCGC (SEQ ID NO:12)CGGCTACCACATCCAAGGAA

[0036] 1.7 Statistical analysis

[0037] The experimental results of this study were expressed as mean ± standard deviation (Mean ± SD), SPSS25.0 software was used for statistical analysis, and GraphPad Prism 9.4.1 software was used for drawing. The inter-group comparison was performed by t-test or Wilcoxon Mann-Whitney two-sample rank sum test, and p < 0.05 was considered statistically significant, and * / # was used to indicate: p>0.05 (ns), p<0.05 (* / #), p<0.01 (** / ##), p<0.001 (*** / ###), p<0.0001 (**** / ####), "*" indicates vs ND-LD; "#" indicates vs HFD-LD.

[0038] 2. Results

[0039] 2.1 Circadian rhythm disturbance induced by light pattern regulation can change the general living state of mice

[0040] like Figure 1 As shown in a, at the end of the second cycle, the weight of mice in the HFD-LD group was significantly higher than that in the ND-LD group, and the difference was statistically significant (p<0.05), and the weight gain rate of mice in the HFD-LD group was significantly faster than that in the ND-LD group. The weight of mice in the HFD-CRD group continued to be slightly lower than that in the HFD-LD group, but the difference was not statistically significant (p>0.05). It can be seen that under normal circadian rhythm conditions, high-fat diet causes mice to gain weight, which is significantly different from mice on a normal diet; circadian rhythm disorders have little effect on the weight of mice on a high-fat diet.

[0041] like Figure 1As shown in b, the ND-LD group mice had a normal diet. The HFD-LD group mice had a significantly lower diet per cycle than the ND-LD group, and the difference was statistically significant (p<0.05). The HFD-CRD group mice had a significantly lower diet during the 6th and 10th cycles than the HFD-LD group, and the difference was statistically significant (p<0.05). Figure 1 c, In a normal light environment, the food intake of mice in the HFD-CRD group during the 10th cycle was significantly lower than that of the HFD-LD group, and the difference was statistically significant (p<0.05). Figure 1 d. In a completely dark environment, the food intake of mice in the HFD-CRD group during the 6th and 9th cycles was significantly lower than that of the HFD-LD group, and the difference was statistically significant (p<0.05). It can be seen that under normal circadian rhythm conditions, high-fat diet leads to a decrease in the food intake of mice, which is significantly different from that of mice on a normal diet; circadian rhythm disorders lead to a further decrease in the food intake of mice on a high-fat diet, which is significantly different from that of mice on a high-fat diet with normal circadian rhythm, and it is less affected by changes in light patterns.

[0042] like Figure 1 As shown in e, the water intake of mice in the ND-LD group was normal. The water intake of mice in the HFD-LD group was significantly lower than that of the ND-LD group per cycle, and the difference was statistically significant (p<0.05). The water intake of mice in the HFD-CRD group during the 1st, 2nd, 4th, 6th, 8th, 9th, 10th, 11th, 13th, and 14th cycles was significantly lower than that of the HFD-LD group, and the difference was statistically significant (p<0.05). Figure 1 f, In a normal light environment, the water intake of mice in the HFD-CRD group was significantly lower than that of the HFD-LD group only during the 3rd and 11th cycles, and the difference was statistically significant (p<0.05). Figure 1 g, In a completely dark environment, the amount of water consumed by mice in the HFD-CRD group during the 1st, 4th, 6th, 8th, 9th, 10th, 11th, 13th, and 14th cycles was significantly lower than that in the HFD-LD group, and the difference was statistically significant (p<0.05). It can be seen that under normal circadian rhythm conditions, high-fat diet leads to a decrease in water intake in mice, which is significantly different from that in mice on a normal diet; circadian rhythm disorders lead to a further decrease in water intake in mice on a high-fat diet, which is significantly different from that in mice on a high-fat diet with normal circadian rhythms, and it is greatly affected by changes in light patterns, and a dark environment will further reduce the amount of water consumed by high-fat mice.

[0043] like Figure 1As shown in h, in a normal light environment, the mice in the ND-LD group were active. The activity of the mice in the HFD-LD group was basically lower than that of the ND-LD group in the resting state for 5 minutes. In the 9th, 10th, and 12th cycles, the activity was significantly less than that of the ND-LD group, and the difference was statistically significant (p<0.05). The activity of the mice in the HFD-CRD group was significantly greater than that of the HFD-LD group in the 1st, 5th, 7th, and 12th cycles, and the difference was statistically significant (p<0.05). It can be seen that under normal circadian rhythm, high-fat diet leads to a significant decrease in the activity of mice, which is significantly different from that of mice on a normal diet; while circadian rhythm disorders will cause stress in mice on a high-fat diet, increase the activity of mice, and have a significant difference compared with mice on a high-fat diet with normal circadian rhythm.

[0044] 2.2 Circadian rhythm disturbance induced by light pattern regulation can change the general living state of mice

[0045] like Figure 2 a. Figure 2 As shown in c, the levels of Rev-erbαmRNA and RorαmRNA in the liver of mice in the HFD-CRD group were significantly higher than those in the HFD-LD group, and the difference was statistically significant (p<0.05); Figure 2 b. Figure 2 d. Figure 2 As shown in Figure e, the mRNA levels of Bmal1, Per1, and Per2 in the liver of mice in the HFD-CRD group were close to those in the HFD-LD group, with no significant difference (p>0.05). This shows that 14 weeks of circadian rhythm disorder led to changes in the rhythm of liver clock genes in mice fed a high-fat diet.

[0046] 2.3 Circadian rhythm disturbance induced by light pattern regulation can aggravate liver damage in NAFLD mice fed a high-fat diet 2.3.1 Serum liver function levels in mice

[0047] like Figure 3 a, The serum ALT and AST levels of mice in the HFD-LD group were significantly higher than those in the ND-LD group, and the difference was statistically significant (p<0.05). Figure 3 b. The serum ALT and AST levels of mice in the HFD-CRD group were significantly higher than those in the HFD-LD group, and the difference was statistically significant (p<0.05). It can be seen that under normal circadian rhythm conditions, high-fat diet causes liver function damage in mice, which is significantly different from that in mice with normal diet; circadian rhythm disorder for 14 weeks aggravates liver function damage in mice with high-fat diet, which is significantly different from that in mice with normal circadian rhythm and high-fat diet.

[0048] 2.3.2 Mouse liver pathological analysis and NAS scoring

[0049] Under light microscopy, Figure 4ab, ND-LD group mice had intact liver lobule structure, with the central vein in the center of the liver lobule, and hepatocytes were arranged radially around the central vein to form liver plates. The hepatic sinusoids connected between liver plates were clearly demarcated, and no pathological phenomena such as fatty degeneration, inflammatory cell infiltration, ballooning, necrotic foci, and fibrosis were observed. Figure 4 cd, the liver lobule structure was disordered in the HFD-LD group, with a large number of enlarged hepatocytes filled with fat vacuoles of varying sizes, and some hepatocyte nuclei were pushed to one side. Fatty degeneration of hepatocytes was mainly located in the hepatic acinar zone III. The fatty degeneration in the NAS score was significantly increased compared with the ND-LD group, and the difference was statistically significant (p<0.05). No obvious inflammatory cell infiltration, ballooning, necrotic foci and fibrosis were observed. Figure 4 ef, the structural disorder of liver lobules in the HFD-CRD group was significantly aggravated, and the fatty degeneration of liver cells was significantly aggravated, and the range expanded to the liver acinar zone I, almost covering the entire liver lobule. The NAS pathological score is shown in Table 2. The fatty degeneration in the NAS score was significantly increased compared with the HFD-LD group, and the difference was statistically significant (p<0.05). In addition, scattered necrotic foci were seen in some liver lobules, and inflammatory cells were infiltrated in the portal area. The lobular inflammation in the NAS score was significantly aggravated compared with the HFD-LD group, and the difference was statistically significant (p<0.05). No obvious ballooning hepatocytes and fibrosis were observed. It can be seen from this that under normal circadian rhythm, high-fat diet only caused obvious fatty degeneration in the liver of mice, which was significantly different from that of mice with normal diet; 14 weeks of circadian rhythm disorder caused further aggravation of fatty degeneration in the liver of mice with high-fat diet, and inflammatory cell infiltration occurred, which was significantly different from that of mice with normal circadian rhythm and high-fat diet.

[0050] Table 2 NAS pathology scoring table

[0051]

[0052]

[0053] This fully proves that the model of the present invention is successfully constructed. The model of the present invention shows low inter-individual heterogeneity and relatively high stability and reproducibility. At the same time, the model constructed by the present invention can reflect the histological characteristics of patients with circadian rhythm disorder and high-fat diet non-alcoholic fatty liver disease, and the model is simple to build, has good universality, and is easy to promote. It can be used as a platform for testing therapeutic drugs and studying the pathogenesis of the disease, and has broad application prospects.

[0054] The above are only examples of the features of the present invention and do not constitute any limitation on the protection scope of the present invention. Any technical solution formed by equivalent exchange or equivalent replacement falls within the protection scope of the present invention.

Claims

1. A method for constructing a mouse model of circadian rhythm disordered non-alcoholic fatty liver disease, characterized in that: The following steps are involved: 1) 6-7 week old mice were fed a 60% high-fat diet and regular drinking water, with free access to food and water; The lighting pattern of the environment in which the mice are kept is adjusted. The specific lighting program of one cycle is as follows: first, 12 hours of light-12 hours of darkness for 3 days, and then 24 hours of darkness for 4 days; A total of 14 steps 2) After the cycle, a mouse model of non-alcoholic fatty liver disease with circadian rhythm disorder induced by changing the light pattern is obtained.

2. The method for constructing a circadian rhythm disorder non-alcoholic fatty liver disease mouse model according to claim 1, characterized in that: The mice were SPF male C57BL / 6J mice.

3. The method for constructing a circadian rhythm disorder non-alcoholic fatty liver disease mouse model according to claim 1, characterized in that: The high-fat diet is specifically a high-fat diet of model D12492 produced by Research Diets, Inc., USA.

4. The method for constructing a circadian rhythm disorder non-alcoholic fatty liver disease mouse model according to claim 2, characterized in that: In step 2), the light intensity is 20 lux.

5. Use of a circadian rhythm disorder non-alcoholic fatty liver disease mouse model constructed by the construction method of claim 1 in studying the effects of circadian rhythm disorder on the occurrence and development of non-alcoholic fatty liver disease.

Citation Information

Patent Citations

  • High-fat feed and application thereof in building animal model with non-alcoholic fatty liver

    CN102106476A

  • Construction method of non-alcoholic fatty liver mouse model

    CN112088837A

  • Non-alcoholic steatohepatitis animal model and construction method therefor

    WO2022211352A1

Cited By

  • Construction method and application of zebra fish circadian rhythm disorder model

    CN120477103A